Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy

Michael Mullette, a former Moderna vice president, is taking a senior leadership position in the MAPS Public Benefit Corporation.

Visit article
Category Scientific / Research
Published in Benzinga
?>